Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1/2 1

Status

Completed 15Terminated 5Unknown 4Recruiting 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Breast Neoplasms 24Colorectal Neoplasms 19Rectal Neoplasms 11Stomach Neoplasms 8Colonic Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Carcinoma, Hepatocellular 7Neoplasm Metastasis 6Squamous Cell Carcinoma of Head and Neck 5Neoplasms 5Liver Neoplasms 5Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4Osteosarcoma 4Esophageal Neoplasms 4Cholangiocarcinoma 4Peritoneal Neoplasms 3Ovarian Neoplasms 3Neuroblastoma 3Multiple Myeloma 3Lung Neoplasms 3Locally Advanced Rectal Cancer 3Kidney Neoplasms 3Inflammatory Breast Neoplasms 3Turcot syndrome 2Sarcoma 2Pancreatic Neoplasms 2Nasopharyngeal Carcinoma 2Head and Neck Neoplasms 2Glioblastoma 2

Interventions

Cisplatin 31Paclitaxel 26Radiotherapy 21Fluorouracil 19camrelizumab 11Radiation 11Oxaliplatin 10Docetaxel 10Carboplatin 9Capecitabine 9Esophagectomy 8Surgical Procedures, Operative 7Radiotherapy, Intensity-Modulated 6Endoscopic Mucosal Resection 6Drug Therapy 6apatinib 5Leucovorin 5Chemoradiotherapy 5nedaplatin 4S 1 (combination) 4Preoperative Exercise 4Neoadjuvant Therapy 4Irinotecan 4Endoscopy 4Cetuximab 4Albumin-Bound Paclitaxel 4pembrolizumab 3TP protocol 3Radiotherapy, Adjuvant 3Epirubicin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Esophageal Neoplasms × Neoadjuvant Therapy × Clear all
NCT05424432 2022-06-27

SCALE-2

Jiangsu Cancer Institute & Hospital

Phase 2 Unknown
63 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT00425425 2014-05-01

Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer

Technical University of Munich

Phase 1/2 Unknown
43 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00041262 2013-08-12

Combination Chemotherapy in Treating Patients With Esophageal Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
1,300 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT01463501 2013-05-14

Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer

Zhejiang Cancer Hospital

Phase 2 Unknown
60 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡